Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trialSanjay Ramakrishnan, Mona Bafadhel, Christine Mwasuku et al.|The Lancet Respiratory Medicine|2024Cited by 98
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational studyImran Howell, Ian Pavord, Hafiz Taha Mahmood et al.|European Respiratory Journal|2025Cited by 5